Author Index

Search or browse for an author across our entire electronic archive

Search results for: G
Results 351 - 360 of 1387 shown below

  • Gelder, C M

    S R Wall, C F Scherf, L Morison, K W Hart, B West, G Ekpo, A N Fiander, S Man, C M Gelder, G Walraven and L K Borysiewicz

    Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology

    advance online publication, 2005-10-11 00:00:00.000;

    doi:10.1038/sj.bjc.6602736

    Abstract | Full article | PDF

  • Gelder, M E Meijer-van

    J A Foekens, M P Look, J Bolt-de Vries, M E Meijer-van Gelder, W L J van Putten and J G M Klijn

    Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients

    doi:10.1038/sj.bjc.6690048

    Abstract | Full article | PDF

  • Gelder, M Meijer-van

    E M J J Berns, I L van Staveren, L Verhoog, A M W van de Ouweland, M Meijer-van Gelder, H Meijers-Heijboer, H Portengen, J A Foekens, L C J Dorssers and J G M Klijn

    Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features

    doi:10.1054/bjoc.2001.1937

    Abstract | Full article | PDF

  • Gelderblom, H

    J S Kloover, M A den Bakker, H Gelderblom and J P van Meerbeeck

    Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens

    doi:10.1038/sj.bjc.6601303

    Abstract | Full article | PDF

  • D M Kweekel, H Gelderblom, T Van der Straaten, N F Antonini, C J A Punt and H-J Guchelaar

    UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study

    advance online publication, 2008-07-01 00:00:00.000;

    doi:10.1038/sj.bjc.6604461

    Abstract | Full article | PDF

  • D M Kweekel, M Koopman, N F Antonini, T Van der Straaten, J W R Nortier, H Gelderblom, C J A Punt and H-J Guchelaar

    GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group

    advance online publication, 2008-09-16 00:00:00.000;

    doi:10.1038/sj.bjc.6604654

    Abstract | Full article | PDF

  • D M Kweekel, N F Antonini, J W R Nortier, C J A Punt, H Gelderblom and H-J Guchelaar

    Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array

    advance online publication, 2009-06-16 00:00:00.000;

    doi:10.1038/sj.bjc.6605134

    Abstract | Full article | PDF

  • H Gelderblom, A Sparreboom, M J A de Jonge, W J Loos, E Wilms, M A Mantel, B Hennis, I Camlett, J Verweij and M E L van der Burg

    Dose and schedule-finding study of oral topotecan and weekly cisplatin in patients with recurrent ovarian cancer

    doi:10.1054/bjoc.2001.2014

    Abstract | Full article | PDF

  • Gele, M Van

    M Van Gele, M Kaghad, J H Leonard, N Van Roy, J M Naeyaert, M L Geerts, S Van Belle, V Cocquyt, J Bridge, R Sciot, C De Wolf-Peeters, A De Paepe, D Caput and F Speleman

    Mutation analysis of P73 and TP53 in Merkel cell carcinoma

    doi:10.1054/bjoc.1999.1006

    Abstract | Full article | PDF

  • Gelibter, A

    G Ferretti, E Bria, D Giannarelli, A Felici, P Papaldo, A Fabi, S Di Cosimo, E M Ruggeri, M Milella, M Ciccarese, F L Cecere, A Gelibter, C Nuzzo, F Cognetti, E Terzoli and P Carlini

    Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials

    advance online publication, 2006-05-30 00:00:00.000;

    doi:10.1038/sj.bjc.6603194

    Abstract | Full article | PDF

  • Gellert, K

    S Petersen, M Aninat-Meyer, K Schlüns, K Gellert, M Dietel and I Petersen

    Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung

    doi:10.1054/bjoc.1999.0878

    Abstract | Full article | PDF

  • Gellert, N

    J Neuzil, T Weber, N Gellert and C Weber

    Selective cancer cell killing by alpha-tocopheryl succinate

    doi:10.1054/bjoc.2000.1559

    Abstract | Full article | PDF

  • Gelly, M

    L Arnould, M Gelly, F Penault-Llorca, L Benoit, F Bonnetain, C Migeon, V Cabaret, V Fermeaux, P Bertheau, J Garnier, J-F Jeannin and B Coudert

    Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism?

    advance online publication, 2006-01-10 00:00:00.000;

    doi:10.1038/sj.bjc.6602930

    Abstract | Full article | PDF

  • Gelmon, K

    D G Bebb, Z Yu, J Chen, M Telatar, K Gelmon, N Phillips, R A Gatti and B W Glickman

    Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer

    doi:10.1038/sj.bjc.6690630

    Abstract | Full article | PDF